Results 161 to 170 of about 409,344 (265)
Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer. [PDF]
Sezgin Y +41 more
europepmc +1 more source
Abstract The addition of a lateral extra‐articular tenodesis to anterior cruciate ligament reconstruction has been shown to reduce graft failure and improve rotational stability, but current fixation methods often require additional tunnels or hardware, with risks of tunnel convergence, irritation, and hardware removal. This technical paper describes a
Emmanouil Papakostas +5 more
wiley +1 more source
Interpretations on nomogram for predicting overall and cancer-specific survival in patients with postoperative follicular thyroid cancer in thyroidology. [PDF]
Sengul I, Sengul D.
europepmc +1 more source
Abstract Medial meniscus posterior root tears frequently result in meniscal extrusion and disruption of normal tibiofemoral contact mechanics. Several techniques, including transtibial pullout and anchor‐based repair methods, are used for root repair and meniscus centralization.
Coşkun Genç +5 more
wiley +1 more source
Correction: Perceptions of cardiovascular risk and the role of psychological factors: a qualitative study among healthy adults in Turkey. [PDF]
Alagöz E, Afşar F.
europepmc +1 more source
Aims At Koç University School of Medicine, a one‐week rational pharmacotherapy (RPHM) programme, modelled after WHO 6‐step, has been introduced in the fourth‐year curriculum to improve prescription skills. For efficient problem‐based learning (PBL) sessions on a prespecified topic, students need to brush up on basic pharmacology knowledge, so we ...
Sinem Ezgi Gülmez +2 more
wiley +1 more source
Prognostic significance of squamous differentiation in pT2N0 urothelial bladder cancer. [PDF]
Coskun A +11 more
europepmc +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source

